PC(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Metabolite details

Identifier

DLRNZUPJXRVWRW-FKZZUUMNSA-N

InChI Key

DLRNZUPJXRVWRW-FKZZUUMNSA-N

IUPAC name

[(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

Preferred name

PC(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

INN name

—

Synonym

—

ChEBI

CHEBI:176401

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• IDH1 Mutations Induce Organelle Defects Via Dysregulated Phospholipids (CSHpos)
• Red-Fleshed Apple Anthocyanin Extracts Attenuate Male Reproductive System Dysfunction Caused by Busulfan in Mice (Mouse blood plasma; UPLC-MS/MS assays)
• Metabolic characterization of the natural progression of chronic hepatitis B (Lipid assays).
• Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.
• Transcript variants of long-chain acyl-CoA synthase 1 have distinct roles in sheep lipid metabolism
• Unraveling the metabolic effects of benzophenone-3 on the endosymbiotic dinoflagellate Cladocopium goreaui
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• Wild_type_vs_hfq
• IDH1R132C_U251_ER_Untreated_vs_IDH1WT_U251_ER_Untreated
• Control_vs_Busulfan_5_mg_kg_RAAE
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Control_vs_Exercise
• Control_12h_vs_Toxocara canis_12h
• Control_Female_vs_Restricted_Female
• Knockdown_vs_Control
• Knockdown_vs_Control
• Control_vs_BP3_Low_Concentration
• BSA_Control_vs_AA